Squamous carcinoma of the mid-esophagus. A survival study.
A survival study for squamous carcinomas of the mid-esophagus treated by Southern California Permanente Medical Group in the interval of 1954 to 1988 was undertaken. Radiation therapy and surgery were equally efficacious in terms of 5-year survival for patients without distant disease and performance status sufficient to tolerate treatment (11% and 16%, respectively). There was no survival benefit for patients treated with palliative surgery. Less invasive endoscopic means along with chemotherapy and radiation for palliation are recommended except for special circumstances. Optimal treatment combinations remain to be discovered.
Harvey
J C
JC
Department of Surgery, Kaiser Permanente Medical Center, Los Angeles, California.
Davidson
W
W
Frankl
H
H
Sachs
T
T
Kagan
A R
AR
D002294:Carcinoma, Squamous Cell / Q000401:mortality* / Q000532:radiotherapy / Q000601:surgery; D004938:Esophageal Neoplasms / Q000401:mortality* / Q000532:radiotherapy / Q000601:surgery; D016629:Esophagectomy / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D010166:Palliative Care; D012189:Retrospective Studies; D016019:Survival Analysis